title: Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging.
abstract: Central nervous system (CNS) adrenergic systems are involved in regulation of behavior and blood pressure. The effects of Alzheimer's disease (AD) and normal aging on resting CNS adrenergic activity were estimated by measuring cerebrospinal fluid (CSF) epinephrine (EPI) concentrations in 74 persons with AD, 42 cognitively normal healthy older persons, and 54 healthy young persons. The responsiveness of CSF EPI to the alpha-2 adrenergic antagonist yohimbine and the alpha-2 adrenergic agonist clonidine was measured in smaller subject groups. Resting CSF EPI was higher in AD than in older or young subjects, and increased with dementia severity in AD subjects. There was no relationship between resting CSF EPI and blood pressure. CSF EPI increased following yohimbine in AD and older subjects but not in young subjects. CSF EPI was unaffected by clonidine in all subject groups. The agitation increase following yohimbine was substantially greater in AD subjects than in older or young subjects. CNS adrenergic activity seems increased in AD, may further increase as AD progresses, and may be involved in the pathophysiology of agitation.
authors.affiliation: VA Puget Sound Health Care System, Mental Illness Research, Education, and Clinical Center, Seattle, WA 98108, USA.
authors.forename: E R
authors.initials: ER
authors.lastname: Peskind
authors.forename: R
authors.initials: R
authors.lastname: Elrod
authors.forename: D J
authors.initials: DJ
authors.lastname: Dobie
authors.forename: M
authors.initials: M
authors.lastname: Pascualy
authors.forename: E
authors.initials: E
authors.lastname: Petrie
authors.forename: C
authors.initials: C
authors.lastname: Jensen
authors.forename: K
authors.initials: K
authors.lastname: Brodkin
authors.forename: S
authors.initials: S
authors.lastname: Murray
authors.forename: R C
authors.initials: RC
authors.lastname: Veith
authors.forename: M A
authors.initials: MA
authors.lastname: Raskind
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000375:Aging / Q000134:cerebrospinal fluid*; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid*; D001794:Blood Pressure / Q000502:physiology; D003000:Clonidine / Q000494:pharmacology; D004837:Epinephrine / Q000134:cerebrospinal fluid*; D005260:Female; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D008297:Male; D015016:Yohimbine / Q000494:pharmacology
chemical_list: D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D015016:Yohimbine; D003000:Clonidine; D004837:Epinephrine